ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726332 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726332; 2) Community: the network communities that were significantly associated with the response to NSC 726332; 3) Molecule: the relationships between components within communities and NSC 726332; 4) MDR: the compounds that were significantly associated with the NSC 726332.

NSC Compound Enrichment Correlation
NSC 110383 Naphtho[1,2-c]quinolizinium, 13-methyl-, chloride 0.00306027196853062 -0.072546098
NSC 129220 O2,2'-Cyclocytidine monoacetate 0.00306027196853062 0.60211825
NSC 333054 Adriamycin, tetrahydropyranyl 0.00306027196853062 0.48497832
NSC 610456 Camptothecin Derivative 0.00306027196853062 0.62557875
NSC 648316 Null 0.00306027196853062 0.59880269
NSC 668281 (-)-.beta.-L-1-[(2-Hydroxymethyl)-1,3-dioxolan-4yl]cytosine 0.00306027196853062 0.51652115
NSC 670656 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer 0.00306027196853062 0.59407592
NSC 676315 Null 0.00306027196853062 0.38857875
NSC 683555 Camptothecin Derivative 0.00306027196853062 0.59890407
NSC 690266 ANTINEOPLASTIC-690266 0.00306027196853062 0.4259772
Total:67  Current:8    [First] [Prev] [Next] [Last]